“醫(yī)學(xué)英語閱讀:仿生學(xué)眼睛使患者重見光明”相信是準(zhǔn)備學(xué)習(xí)醫(yī)學(xué)英語的朋友比較關(guān)注的事情,為此,醫(yī)學(xué)教育網(wǎng)小編整理內(nèi)容如下:
Six blind or near-bl 0
six blind or near-blind people can now see light and in some cases pick out shapes and recognize faces after having an artificial retina2)inserted into their eyes,says the co-inventor of the device.the findings show that the bionic eye may restore some sight for the blind and raise hopes for the estimated 10million americans afflicted with blinding eye diseases.
alan chow,the ophthalmologist3)who helped invent the artificial silicon retina,and his colleagues tucked the computer retinas into a slit they made in the eyes of six people blinded by retinitis pigmentosa4),a rare progressive degeneration5)of the retina.solar cells in the device's microchip are supposed to replace the function of the retina's light-sensing cells.doctors followed the patients for up to 21months,and preliminary evidence hints that the device is working:all six had substantial6)improvement in their vision,says chow.researchers reported no signs of infection in the patients.
chow's company,optobionics corp.of wheaton,ill.,is developing the artificial retina and hopes to have it on the market within five years.
by kathleen fackelmann
一種人造視網(wǎng)膜的合作發(fā)明者說,6位全盲或幾乎全盲的患者在植入這種視網(wǎng)膜后看到了光線,有些人還分辨出了形狀和面孔。這項研究成果表明,仿生學(xué)眼睛也許能使盲人恢復(fù)一定程度的視力,從而給大約1000萬患有盲眼病而影響視覺的美國人帶來希望。
參與發(fā)明人造硅視網(wǎng)膜工作的眼科專家艾倫·周與他的同事在6名色素性視網(wǎng)膜炎患者的眼睛上做一個切口,然后把這種計算機視網(wǎng)膜植入切口。色素性視網(wǎng)膜炎是視網(wǎng)膜發(fā)生的罕見進(jìn)行性病變。該裝置微芯片里的太陽能電池是用來替代視網(wǎng)膜感光細(xì)胞的功能的。醫(yī)生對這些患者進(jìn)行了為期21個月的跟蹤研究。初步跡象表明人造視網(wǎng)膜發(fā)揮了作用。周說,所有6名患者的視力都有實質(zhì)性的改進(jìn)。研究人員目前還沒有發(fā)現(xiàn)患者出現(xiàn)感染的跡象。周所在的伊利諾伊州惠頓視力仿生學(xué)公司正在開發(fā)這種人造視網(wǎng)膜,希望在5年內(nèi)將其投放市場
bionic adj.仿生學(xué)的,利用仿生學(xué)的
retina n.視網(wǎng)膜
ophthalmologist n.眼科專家
retinitis pigmentosa n.色素性視網(wǎng)膜炎
degeneration n.惡化
substantial adj.實質(zhì)性的
以上是醫(yī)學(xué)教育網(wǎng)小編整理的“醫(yī)學(xué)英語閱讀:仿生學(xué)眼睛使患者重見光明”全部內(nèi)容,想了解更多醫(yī)學(xué)英語知識及內(nèi)容,請點擊醫(yī)學(xué)教育網(wǎng)。